In 2023, Kashiwaga et al. proposed diagnostic criteria for ITP involving isolated thrombocytopenia with no evidence of dysplasia of any blood cell type on the blood smear, a normal or slightly increased thrombopoietin (TPO) level, elevated IPF, and absence of other causes [12]. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.